Hudson Bay Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.7M Sell
2,212,690
-257,720
-10% -$1.48M 0.04% 213
2025
Q1
$20.2M Buy
2,470,410
+665,610
+37% +$5.43M 0.06% 145
2024
Q4
$17M Buy
1,804,800
+379,800
+27% +$3.58M 0.06% 166
2024
Q3
$15.2M Buy
1,425,000
+357,500
+33% +$3.82M 0.06% 123
2024
Q2
$10.6M Buy
1,067,500
+265,000
+33% +$2.63M 0.05% 165
2024
Q1
$9.45M Buy
802,500
+442,500
+123% +$5.21M 0.05% 145
2023
Q4
$5.11M Buy
360,000
+185,000
+106% +$2.63M 0.03% 251
2023
Q3
$2.13M Buy
175,000
+20,000
+13% +$243K 0.02% 402
2023
Q2
$1.95M Buy
155,000
+30,000
+24% +$377K 0.01% 446
2023
Q1
$1.39M Hold
125,000
0.01% 524
2022
Q4
$1.53M Hold
125,000
0.02% 611
2022
Q3
$1.31M Sell
125,000
-55,000
-31% -$574K 0.01% 783
2022
Q2
$1.93M Buy
180,000
+131,204
+269% +$1.41M 0.01% 771
2022
Q1
$462K Buy
+48,796
New +$462K 0.01% 859
2021
Q4
Sell
-250,000
Closed -$2.39M 1102
2021
Q3
$2.39M Sell
250,000
-65,000
-21% -$621K 0.03% 568
2021
Q2
$3.04M Buy
+315,000
New +$3.04M 0.04% 483
2020
Q3
Sell
-39,900
Closed -$601K 560
2020
Q2
$601K Sell
39,900
-65,100
-62% -$981K 0.01% 389
2020
Q1
$970K Sell
105,000
-45,000
-30% -$416K 0.02% 323
2019
Q4
$1.46M Buy
150,000
+38,400
+34% +$374K 0.03% 288
2019
Q3
$895K Buy
111,600
+71,600
+179% +$574K 0.02% 302
2019
Q2
$499K Hold
40,000
0.01% 314
2019
Q1
$544K Sell
40,000
-110,000
-73% -$1.5M 0.01% 359
2018
Q4
$1.44M Buy
150,000
+10,000
+7% +$95.8K 0.02% 317
2018
Q3
$1.69M Buy
140,000
+40,000
+40% +$484K 0.02% 303
2018
Q2
$1.56M Sell
100,000
-100,000
-50% -$1.56M 0.02% 315
2018
Q1
$3.01M Buy
200,000
+100,000
+100% +$1.5M 0.06% 196
2017
Q4
$1.44M Hold
100,000
0.03% 257
2017
Q3
$1.51M Sell
100,000
-100,000
-50% -$1.51M 0.04% 208
2017
Q2
$2.01M Sell
200,000
-100,000
-33% -$1.01M 0.04% 204
2017
Q1
$2.14M Buy
+300,000
New +$2.14M 0.03% 197